Chu, Min Kyung
Article History
First Online: 4 January 2019
Competing interests
: M.K.C. declares that he has served as a site investigator for a multicentre trial sponsored by Eli Lilly, Novartis International and Otsuka Korea; is an advisory committee member for Teva; and has received lecture honoraria from Allergan Korea and the Yuyu Pharmaceutical Company.